Special Issue "Mechanisms of Regulatory T Cell, B Cell, and Myeloid Suppressor Cell Activity"

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".

Deadline for manuscript submissions: 15 December 2023 | Viewed by 192

Special Issue Editors

Department of Neurology, Harvard Medical School, Boston, MA, USA
Interests: autoimmunity; neuroinflammation; cancer; inflammation; T cells; myeloid cells; microRNA; non-coding RNA
Lymphocyte B et Auto Immunité (LBAI), Brest, France
Interests: autoimmunity; immunology; cytokines
State Key Laboratory of Membrane Biology, Institute of Zoology, University of Chinese Academy of Sciences, Beijing 100101, China
Interests: immunology; transplantation immunology; immune tolerance; innate immune cells

Special Issue Information

Dear Colleagues,

The elegant control of appropriate immune homeostasis and immune response in physiological and pathological conditions is important and significant. Among many immune regulatory mechanisms, regulatory immune cells such as regulatory T cells, regulatory B cells, and myeloid suppressor cells play critical roles in these processes. The abnormal activity of these regulatory cells is involved in many human diseases, such as cancers, autoimmune diseases, ageing and degenerative diseases, and the graft rejection process. A deep understanding of the immunobiology of these cells would help us to uncover the relevant pathophysiological processes of relevant diseases and identify novel therapeutic approaches.

This Special Issue will cover the basic and clinical aspects of regulatory T cells, regulatory B cells, and myeloid suppressor cells, including but not limited to the identification of new subpopulations; methods and biomarkers to isolate and maintain these cells ex vivo; the regulation of extracellular and intracellular molecules in cell differentiation and biological functions; the role of these cells in diseases, ageing and graft rejection; drug screening for these cells; the bioengineering of these cells; and the application of these cells in pre-clinical and clinical settings.

In this Special Issue of Cells we invite your contributions, in the form of original research articles or reviews, on all aspects related to recent advances in the fields of T cells, B cells, and myeloid suppressor cells.

Dr. Gopal Murugaiyan
Dr. Sophie Hillion
Prof. Dr. Yong Zhao
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • regulatory T cell
  • regulatory B cell
  • myeloid suppressor cells
  • immune regulation
  • immune tolerance
  • immune disease
  • immune cell therapy

Published Papers

This special issue is now open for submission.
Back to TopTop